Existing FDA-Approved Biosimilars

Jonathan Kay, MD, provides an overview of the existing FDA-approved biosimilars for adalimumab.

Related Keywords

Jonathan Kay , ,Biosimilars Stakeholder Summit ,Interchangeable Biosimilars ,Inflammatory Diseases ,Fda Approved Biosimilars ,Adalimumab ,Citrate Free Buffer ,Adalimumab Biosimilar ,50 Mg Concentration ,100 Mg Concentration ,Patient Assistance Program ,